Abstract:Engineering single base edits using CRISPR technology including specific deaminases and single-guide RNA (sgRNA) is a rapidly evolving field. Different types of base edits can be constructed, with cytidine base editors (CBEs) facilitating transition of C-to-T variants, adenine base editors (ABEs) enabling transition of A-to-G variants, C•G-to-G•C transversion base editors (CGBEs) and recently adenine transversion editors (AYBE) that create A-to-C and A-to-T variants. The base-editing machine learning algorithm BE-Hive predicts which sgRNAs and base editor constructs have the strongest likelihood of achieving desired base edits. We have used BE-Hive and TP53 mutation data from The Cancer Genome Atlas ovarian cancer cohort to predict which mutations can be engineered, or reverted to wild-type sequence, using CBEs, ABEs or CGBEs. We have developed and automated a ranking system to assist in selecting optimally designed sgRNA that considers the presence of a suitable protospacer adjacent motif (PAM), the frequency of predicted bystander edits, editing efficiency and target base change. We have generated single constructs containing ABE or CBE editing machinery, an sgRNA cloning backbone and an enhanced green fluorescent protein tag (EGFP), removing the need for co-transfection of multiple plasmids. We have tested our ranking system and new plasmid constructs to engineer the p53 mutants Y220C, R282W and R248Q into wild-type p53 cells and shown that these mutants cannot activate four p53 target genes, mimicking the behaviour of endogenous p53 mutations. This field will continue to rapidly progress, requiring new strategies such as we propose to ensure desired base-editing outcomes.

Automated high-throughput genome editing platform with an AI learning in situ prediction model

Whole-genome Epigenetic Function Annotation Through Sgrna Libraries Synthesized by Controlled Template-Dependent Elongation

Development and application of CRISPR/Cas9 technologies in genomic editing.

Comprehensive evaluation and prediction of editing outcomes for near-PAMless adenine and cytosine base editors

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

Optimization of C-to-G base editors with sequence context preference predictable by machine learning methods

The Development and Application of a Base Editor in Biomedicine

Disease modeling by efficient genome editing using a near PAM-less base editor in vivo

Design of highly functional genome editors by modeling the universe of CRISPR-Cas sequences

Crispr-Based Editing of Human Pluripotent Stem Cells for Disease Modeling

Helicase-assisted continuous editing for programmable mutagenesis of endogenous genomes

Base Editing Mediated Generation of Point Mutations Into Human Pluripotent Stem Cells for Modeling Disease

An in situ cut-and-paste genome editing platform mediated by CRISPR/Cas9 or Cas12a

Accelerated discovery and miniaturization of novel single-stranded cytidine deaminases

ACBE, a new base editor for simultaneous C-to-T and A-to-G substitutions in mammalian systems

Engineering APOBEC3A deaminase for highly accurate and efficient base editing

Advancing CRISPR base editing technology through innovative strategies and ideas

Multiplexed base editing through Cas12a variant-mediated cytosine and adenine base editors

Machine Learning and Directed Evolution of Base Editing Enzymes

CRISPR single base-editing: in silico predictions to variant clonal cell lines